CroíValve develops medical device solutions focused on treating tricuspid regurgitation, a heart valve condition where blood flows backward due to improper valve closure. The company creates the DUO™ System, a minimally invasive transcatheter valve technology designed to support the function of the native tricuspid valve while preserving heart anatomy. The DUO™ System combines a coaptation valve and an anchor system to address valve leakage and adapt to different patient anatomies. CroíValve’s work focuses on developing treatment options for patients with limited alternatives by advancing catheter-based approaches for structural heart care. The company continues clinical development of its technology to evaluate its use in managing tricuspid valve disease.